Navigation Links
Verity Radiation Therapy Becomes Second U.S. Medical Center to Treat Cancer Patients Using RapidArc(TM) Radiotherapy Technology
Date:5/27/2008

New technology from Varian Medical Systems delivers faster image-guided intensity-modulated radiotherapy (IMRT) to target tumors while sparing more

healthy tissue

PLANO, Texas, May 27 /PRNewswire-FirstCall/ -- Earlier this week, Verity Radiation Therapy, at The Texas Clinic at Prestonwood, became the second medical center in the United States to commence treating cancer patients with RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR) earlier this week. RapidArc is an advanced form of image-guided, intensity-modulated radiation therapy (IMRT) that can be delivered two to eight times faster than is possible with conventional IMRT or helical tomotherapy.

"We delivered our first RapidArc treatment yesterday, to a patient with prostate cancer who was about two weeks into an eight and a half week course of traditional IMRT treatments," said Dr. Ed Gilbert, radiation oncologist. "Before, his treatments were taking about 10 minutes each day to complete. Yesterday, using the RapidArc approach, we completed the entire process in about 6 minutes. That included positioning the patient, taking images, adjusting his position, and delivering the treatment. Actual treatment delivery was completed in less than 90 seconds, compared to five and a half minutes with the conventional approach."

RapidArc treatments, created with Varian's Eclipse(TM) treatment planning system and proprietary RapidArc software, are faster because they use a Varian linear accelerator to deliver a complete volumetric IMRT treatment with a single rotation of the treatment machine around the patient. Conventional IMRT required the machine to make intermittent stops and starts during a treatment, as the machine was moved to deliver the beam from several different beam angles. Varian treatment planning analyses have shown that RapidArc plan dose distributions are comparable to those possible with conventional IMRT planning, and RapidArc plans are delivered with the same precision.

"IMRT was already a tremendous gain in curving around normal structures, such as the rectum in prostate cancer treatment, thereby allowing for higher doses given to the prostate," Dr. Gilbert pointed out. "The ability to deliver these treatments so much faster is a real win for us and for our patients. Faster treatments are not only more comfortable for the patient, but they have the potential to spare more healthy tissue during the course of treatment since there is less likelihood that the patient will move during the treatment, or that some normal physiological process, such as gas moving through the digestive system, will displace the tumor."

"In addition to shortening the patient's treatment time, with RapidArc we are able to reduce the amount of radiation generated by the machine," added Randi Aaronson, PhD, medical physicist. "While the dose to the target does not change, the dose to the rest of the body from scatter and leakage radiation is reduced compared to conventional IMRT."

"With the addition of RapidArc, the Varian linear accelerator at The Texas Clinic can now be used for an even broader spectrum of advanced clinical capabilities, which already include fixed-beam IMRT, stereotactic treatments, and electron treatments for tumors near the body's surface," added Matt McNeeley, director of marketing and business development. "It is part of our ongoing commitment to offering our patients the most appropriate form of treatment available, based on each patient's unique clinical situation."

About The Texas Clinic at Prestonwood (TTCAP)

The Texas Clinic at Prestonwood offers patients an advanced multi-specialty destination for complete wellness, providing an assortment of medical treatments and services. Set on 4.17 acres, TTCAP features some of the most advanced medical technology in North Texas, including the first Siemens 128-slice, dual source CT in the region; North Texas' first Varian Trilogy(R) linear accelerator, with on-board CT x-ray imaging and RapidArc; one of the few Siemens 3-Tesla MRI units outside a hospital in the area, a Hologic Digital Mammography unit, DEXA and 3D/4D Ultrasound and two vaults for delivery of Image-Guided Intensity Modulated Radiation Therapy (IMRT) and Stereotactic Radiosurgery. Physician specialties include Urology, Oncology, Cardiology, Emergency Care, and full service surgery suite. http://www.txclin.com

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,600 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

FOR INFORMATION CONTACT:

Meryl Ginsberg, Varian Medical Systems

650-424-6444 or meryl.ginsberg@varian.com

Matt McNeeley, Verity Radiation Therapy

972.820.1400 or mmcneeley@veritytherapy.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis
2. GPS Devices Measure Severity of Peripheral Artery Disease
3. In silico modeling helps predict severity of mitochondrial disease
4. Factor key to severity of community-associated methicillin-resistant staph infections identified
5. Cumulative radiation exposure shows increased cancer risk for emergency department patients
6. Radiation Improves Survival for Advanced Prostate Cancer
7. Invasive methods unnecessary for prostate cancer radiation therapy treatment planning
8. Radiation for Prostate Cancer Raises Risk of Other Cancers
9. Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
10. Space Radiation a Risk for Astronauts
11. Radiation beneficial for older breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... 2017 partnership with The Jensie Gran Fondo of Marin. For the second year ... with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our safe, ...
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO ... the National Institute for Health and Care Excellence (NICE) framework. The ... National Health Service (NHS) to search, order and purchase medical and healthcare-related content ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: